全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...
PLOS Medicine  2007 

Lethal Injection for Execution: Chemical Asphyxiation?

DOI: 10.1371/journal.pmed.0040156

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Lethal injection for execution was conceived as a comparatively humane alternative to electrocution or cyanide gas. The current protocols are based on one improvised by a medical examiner and an anesthesiologist in Oklahoma and are practiced on an ad hoc basis at the discretion of prison personnel. Each drug used, the ultrashort-acting barbiturate thiopental, the neuromuscular blocker pancuronium bromide, and the electrolyte potassium chloride, was expected to be lethal alone, while the combination was intended to produce anesthesia then death due to respiratory and cardiac arrest. We sought to determine whether the current drug regimen results in death in the manner intended. Methods and Findings We analyzed data from two US states that release information on executions, North Carolina and California, as well as the published clinical, laboratory, and veterinary animal experience. Execution outcomes from North Carolina and California together with interspecies dosage scaling of thiopental effects suggest that in the current practice of lethal injection, thiopental might not be fatal and might be insufficient to induce surgical anesthesia for the duration of the execution. Furthermore, evidence from North Carolina, California, and Virginia indicates that potassium chloride in lethal injection does not reliably induce cardiac arrest. Conclusions We were able to analyze only a limited number of executions. However, our findings suggest that current lethal injection protocols may not reliably effect death through the mechanisms intended, indicating a failure of design and implementation. If thiopental and potassium chloride fail to cause anesthesia and cardiac arrest, potentially aware inmates could die through pancuronium-induced asphyxiation. Thus the conventional view of lethal injection leading to an invariably peaceful and painless death is questionable.

 References

[1]  Denno D (2002) When legislatures delegate death: The troubling paradox behind state uses of electrocution and lethal injection and what it says about us. Ohio State Law Journal 63: 63–260. Available at: http://moritzlaw.osu.edu/lawjournal/issu？es/volume63/number1/denno.pdf. Accessed 16 March 2007.
[2]  Fellner J, Tofte S (2006) So long as they die: Lethal injection in the United States. Human Rights Watch. Available at: http://hrw.org/reports/2006/us0406. Accessed 16 March 2007.
[3]  Oklahoma Statute Title. (1977 supp). Available at: http://www.lsb.state.ok.us/osstatuestitl？e.html. Accessed 16 March 2007.
[4]  United States District Court, Western District of Oklahoma (20 July 2005) Complaint and Motion to Dismiss, Anderson v. Evans. Case Number 5–825. pp. 25–34. Document Number 1, pp.
[5]  US District Court, Western District of Oklahoma (6 September 2005) Complaint and Motion to Dismiss, Anderson v. Evans. Case Number 5–825. pp. 3–4. Document Number 26, pp.
[6]  Dundee JW (1960) Alterations in response to somatic pain associated with anaesthesia. II. The effect of thiopentone and pentobarbitone. Br J Anaesth 32: 407–414.
[7]  Koniaris LG, Zimmers TA, Lubarsky DA, Sheldon JP (2005) Inadequate anaesthesia in lethal injection for execution. Lancet 365: 1412–1414.
[8]  North Carolina Department of Correction (2007) News regarding scheduled executions. Available at: http://www.doc.state.nc.us/dop/deathpena？lty/execution_news.htm. Accessed: 19 March 2007.
[9]  United States District Court, Northern District of California (20 January 2006) Exhibit A to Motion for TRO, Morales v. Hickman. Case Number 6–219. San Quentin Operational Procedure No. 770. Available at: http://www.law.berkeley.edu/clinics/dpcl？inic/Lethal%20Injection%20Documents/Cali？fornia/Morales/Morales%20Dist%20Ct.Cp/Ex？%20A%20to%20TRO%20motion%20(Procedure%20？No.%20770).pdf. Accessed 16 March 2007.
[10]  United States District Court, Northern District of California (20 January 2006) Exhibit 2 to Exhibit C in Motion for TRO, Morales v. Hickman. Case Number 6–219. Document Number 15–2. Available at: http://www.law.berkeley.edu/clinics/dpcl？inic/Lethal%20Injection%20Resource%20Pag？es/resources.ca.html. Accessed 16 March 2007.
[11]  United States Supreme Court (6 March 2007) Brief for Amicus Habeas Corpus Resource Center, Hill v. McDonough. Case Number 05–8794. Available at: http://www.law.berkeley.edu/clinics/dpcl？inic/Lethal%20Injection%20Documents/Flor？ida/Hill/2006.03.06%20amicus%20hcrc.pdf. Accessed 16 March 2007.
[12]  United States District Court, Eastern District of North Carolina (31 October 2005) Polk Deposition, Page v. Beck. Case Number 5:04-ct-4. Document Number 98.
[13]  United States District Court, Eastern District of North Carolina (3 November 2005) Second Heath Affidavit, Page v. Beck. Case Number 4–04. Document Number 102.
[14]  United States District Court, Eastern District of North Carolina (27 September 2004) Affidavit of Dershwitz, Perkins v. Beck. Case Number 04–643. pp. 22–31. Document Number 7, pp.
[15]  United States District Court, Eastern District of North Carolina (7 April 2006) Order, Brown v. Beck. Case Number 5:06-CT-3018-H. Available at: http://deathpenaltyinfo.org/Brownorder.p？df. Accessed 16 March 2007.
[16]  United States District Court, Northern District of California (25 January 2006) Second Declaration of Dr. Mark Heath, Morales v. Hickman. Case Number 06–219. Document Number 22–1.
[17]  United States District Court, Northern District of California (20 January 2006) Declaration of Patterson, Morales v. Hickman. Case Number 06–219. Document Number 14. Available at: http://www.law.berkeley.edu/clinics/dpcl？inic/Lethal%20Injection%20Documents/Cali？fornia/Morales/Morales%20Dist%20Ct.Cp/Ex？%20B%20to%20TRO%20Motion.pdf. Accessed 16 March 2007.
[18]  United States District Court, Northern District of California (20 January 2006) Declaration of Rocconi, Morales v. Hickman. Case Number 06–219. Document Number 15–4. Available at : http://www.law.berkeley.edu/clinics/dpcl？inic/Lethal%20Injection%20Documents/Cali？fornia/Morales/Morales%20Dist%20Ct.Cp/Ex？%203%20to%20Heath%20Decl%20(Rocconi%20De？cl%20re.%20Anderson%20execution).pdf. Accessed 16 March 2007.
[19]  Steinbrook R (2006) New technology, old dilemma—Monitoring EEG activity during executions. N Engl J Med 354: 2525–2527.
[20]  Abbott Laboratories (1993 November) Pentothal for injection, USP (Thiopental Sodium) Reference 06–8965-R10. A similar document is available at: http://www.rxlist.com/cgi/generic/thiope？ntal.htm. Accessed 16 March 2007.
[21]  Werner HW, Pratt TW, Tatum AL (1937) A comparative study of several ultrashort-acting barbiturates, nembutal, and tribromethanol. J Pharmacol Exp Ther 60: 189–197.
[22]  Robinson MH (1945) The effect of different injection rates on upon the AD50, LD50 and anesthetic duration of pentothal in mice, and strength-duration curves of depression. J Pharmacol Exp Ther 85: 176–191.
[23]  (1994) Administration and compounding of euthanasic agents. The Hague: Royal Dutch Society for the Advancement of Pharmacy.
[24]  United States District Court, Northern District of California (20 January 2006) Declaration of Dershwitz, Morales v. Woodford. Case Number 06–219. Document Number 15.
[25]  Harris WH (1943) Collapse under pentothal sodium. Lancet 242: 173–174.
[26]  Taylor JD, Richards RK, Tabern DL (1951) Metabolism of 35S thiopental (pentothal): Chemical and paper chromatographic studies of 35S excretion by the rat and monkey. J Pharmacol Exp Ther 104: 93–102.
[27]  (2005) Freedom of Information Summary. Original Abbreviated New Animal Drug Application. Euthanasia-III Solution. Rockville (Maryland): Food and Drug Administration. Available at: http://www.fda.gov/cvm/FOI/200–280020305？.pdf. Accessed 6 March 2007.
[28]  Wetherton AR, Corey TS, Buchino JJ, Burrows AM (2003) Fatal intravenous injection of potassium in hospitalized patients. Am J Forensic Med Pathol 24: 128–131.
[29]  Gensia Sicor Pharmaceuticals (2003 October) Pancuronium bromide injection (prescribing information and material safety data sheet). Available at: http://www.sicor.com/products/1044.html. Accessed 16 March 2007.
[30]  Mehta MP, Sokoll MD, Gergis SD (1988) Accelerated onset of non-depolarizing neuromuscular blocking drugs: Pancuronium, atracurium and vecuronium. A comparison with succinylcholine. Eur J Anaesthesiol 5: 15–21.
[31]  Tisch C, Krueger C (14 December 2006) Second dose needed to kill inmate. St Petersburg Times. St. Petersburg: Available at: http://www.sptimes.com/2006/12/14/State/？Second_dose_needed_to.shtml. Accessed 16 March 2007.
[32]  United States Supreme Court (6 March 2006) Brief for Amicus Curiae, Darick Demorris Walker, Hill v. McDonough. Case Number 05–8794. Available at: http://www.jenner.com/files/tbl_s69NewsD？ocumentOrder/FileUpload500/674/Brief_Ami？cus_Curiae_Walker.pdf. Accessed 16 March 2007.
[33]  Brodie BB, Mark LC, Lief PA, Bernstein E, Papper EM (1951) Acute tolerance to thiopental. J Pharmacol Exp Ther 102: 215–218.
[34]  Heard KM (1936) Pentothal: A new intravenous anesthetic. Can Med Assn J 34: 628–634.
[35]  Mallison FB (1937) Pentothal sodium in intravenous anaesthesia. Lancet 230: 1070–1073.
[36]  Kohn DF, Wixson SK, White WJ, Benson GJ, editors. (1997) Anesthesia and analgesia in laboratory animals. New York: Academic Press. 426 p.
[37]  Plumb DC (2005) Veterinary drug handbook. 5th Ed. Stockholm (Wisconsin): PharmaVet. 929 p.
[38]  Mordenti J, Chappell W (1989) The use of interspecies scaling in toxicokinetics. In: Yacobi A, Kelly J, Batra V, editors. Toxicokinetics and new drug development. New York: Pergamon Press. pp. 42–96.
[39]  Center for Drug Evaluation and Research (2005) Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Rockville (Maryland): Food and Drug Administration. Available at: http://www.fda.gov/CDER/GUIDANCE/5541fnl？.htm. Accessed 16 March 2007.
[40]  Hannon JP, Bossone CA, Wade CE (1990) Normal physiological values for conscious pigs used in biomedical research. Lab Anim Sci 40: 293–298.
[41]  United States District Court, Northern District of California (15 February 2006) Memorandum of Intended Decision; Request for Response from Defendants, Morales v. Tilton. Case Number C 06–219, C 06–926. Available at: http://www.deathpenaltyinfo.org/CalifLet？halInjection.pdf. Accessed 16 March 2007.
[42]  Koniaris LG, Sheldon JP, Zimmers TA (2007) Can lethal injection for execution really be “fixed”? Lancet 369: 352–353.
[43]  Mirsky JH, Giarman NJ (1955) Studies on the potentiation of thiopental. J Pharmacol Exp Ther 114: 240–249.
[44]  Richards RK, Taylor JD, Kueter KE (1953) Effect of nephrectomy on the duration of sleep following administration of thiopental and hexobarbital. J Pharmacol Exp Ther 108: 461–473.
[45]  Gruber CM, Gruber JCM, Colosi N (1937) The effects of anesthetic doses of sodium thio-pentobarbital, sodium thio-ethamyl and pentothal sodium upon the respiratory system, the heart and blood pressure in experimental animals. J Pharmacol Exp Ther 60: 143–147.
[46]  Ramsey H, Haag HB (1946) The synergism between the barbiturates and ethyl alcohol. J Pharmacol Exp Ther 88: 313–322.
[47]  Wyngaarden JB, Woods LA, Ridley R, Seevers MH (1948) Anesthetic properties of sodium 5-allyl-5-(1-methyl-butyl)-2-thiobarbitu？rate(surital) and certain other thiobarbiturates in dogs. J Pharmacol Exp Ther 95: 322–327.
[48]  Sharma RP, Stowe CM, Good AL (1970) Studies on the distribution and metabolism of thiopental in cattle, sheep, goats and swine. J Pharmacol Exp Ther 172: 128–137.
[49]  Komar E (1991) Intravenous anaesthesia in the sheep. Proc Int Congr Vet Anesth, 4th. Utrecht (The Netherlands): pp. 209–210.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133